Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Fine
Daniel F Martin
Peter Kirkpatrick

Showing results (11-20 of 252) with videos related to

Pageof 26
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 11, 2007
The investigators' perspective on the collaborative ocular melanoma studyStuart L Fine, Barbara S Hawkins
Ophthalmology|September 25, 2016
Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment: Personal ReminiscencesStuart L Fine, Morton F Goldberg, William Tasman
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Laser prophylaxis for age-related macular degenerationJason Hsu, Maureen G Maguire, Stuart L Fine
Ophthalmology|May 20, 2008
Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trialMaureen G Maguire, Judith Alexander, Stuart L Fine, et al.
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|March 24, 2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results, , Daniel F Martin, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Medicinal chemistry: Shades of chemical beautyPeter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2012
Antiparasitic drugs: Two-pronged tactics for malaria controlPeter Kirkpatrick
Nature Reviews. Drug Discovery|April 7, 2009
Specificity concerns with antibodies for receptor mappingPeter Kirkpatrick
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Pageof 26

Showing results (11-20 of 252) with videos related to

Sort By:
Pageof 26
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 11, 2007
The investigators' perspective on the collaborative ocular melanoma studyStuart L Fine, Barbara S Hawkins
Ophthalmology|September 25, 2016
Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment: Personal ReminiscencesStuart L Fine, Morton F Goldberg, William Tasman
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Laser prophylaxis for age-related macular degenerationJason Hsu, Maureen G Maguire, Stuart L Fine
Ophthalmology|May 20, 2008
Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trialMaureen G Maguire, Judith Alexander, Stuart L Fine, et al.
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|March 24, 2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results, , Daniel F Martin, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Medicinal chemistry: Shades of chemical beautyPeter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2012
Antiparasitic drugs: Two-pronged tactics for malaria controlPeter Kirkpatrick
Nature Reviews. Drug Discovery|April 7, 2009
Specificity concerns with antibodies for receptor mappingPeter Kirkpatrick
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Pageof 26